Catalyst Wire Dossier Catalyst Wire Dossier

Salmeterol/Fluticasone Propionate Inhalation Powder

salmeterol/fluticasone propionate · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Salmeterol/Fluticasone Propionate Inhalation Powder, covering 2013-07-30 to 2013-07-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the 24 Hour Spirometric Effect (FEV1) of Fluticasone Furoate/Vilanterol Inhalation Powder (100mcg Fluticasone Furoate (FF)/25mcg Vilanterol (VI)) Compared With Salmeterol/Fluticasone Propionate Inhalation Powder (50mcg Salmeterol/500mcg Fluticasone Propionate (FP)) [Phase 3]

See pricing